Dyne Therapeutics Inc
NASDAQ:DYN

Watchlist Manager
Dyne Therapeutics Inc Logo
Dyne Therapeutics Inc
NASDAQ:DYN
Watchlist
Price: 30.01 USD -3.88%
Updated: May 29, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

522.3m
+216%
Assets
Growth Rates:
1 Year
+81%
3 Years
+6%
5 Years
-
7 Years
-
10 Years
-
44.2m
-40%
Liabilities
Growth Rates:
1 Year
-5%
3 Years
+228%
5 Years
-
7 Years
-
10 Years
-
478.1m
+424%
Equity
Growth Rates:
1 Year
+98%
3 Years
0%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Dyne Therapeutics Inc

522.3m
Assets
44.2m
Liabilities
522.3m
Assets
44.2m
Liabilities
Current Assets 488.1m
Cash & Short-Term Investments 453.5m
Other Current Assets 34.6m
Non-Current Assets 34.1m
PP&E 32.2m
Other Non-Current Assets 1.9m
Current Liabilities 22.4m
Accounts Payable 7.2m
Accrued Liabilities 15.1m
Non-Current Liabilities 21.9m
Other Non-Current Liabilities 21.9m

Balance Sheet
Dyne Therapeutics Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
8
15
301
201
172
122
Cash Equivalents
8
15
301
201
172
122
Short-Term Investments
0
0
45
176
84
1
Other Current Assets
0
0
4
6
10
6
Total Current Assets
8
15
349
382
266
129
PP&E Net
0
2
2
41
38
33
PP&E Gross
0
2
2
41
38
33
Accumulated Depreciation
0
0
1
2
4
5
Other Long-Term Assets
0
0
2
2
2
2
Total Assets
8
N/A
16
+98%
353
+2 054%
426
+20%
306
-28%
165
-46%
Liabilities
Accounts Payable
1
1
3
4
5
23
Accrued Liabilities
0
1
8
25
23
28
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
0
Total Current Liabilities
1
2
11
29
28
51
Long-Term Debt
0
0
0
0
0
0
Other Liabilities
3
0
0
29
26
23
Total Liabilities
4
N/A
2
-41%
11
+358%
58
+423%
54
-6%
74
+37%
Equity
Common Stock
9
27
0
0
0
0
Retained Earnings
5
20
79
229
397
633
Additional Paid In Capital
0
6
422
597
650
724
Other Equity
0
0
0
0
1
0
Total Equity
4
N/A
14
+233%
342
+2 346%
368
+8%
252
-31%
91
-64%
Total Liabilities & Equity
8
N/A
16
+98%
353
+2 054%
426
+20%
306
-28%
165
-46%
Shares Outstanding
Common Shares Outstanding
44
44
45
52
56
61

See Also

Summary
DYN intrinsic value, competitors valuation, and company profile.
DCF Valuation
DYN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DYN stock valuation using valuation multiples.
Wall Street Estimates
DYN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DYN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 141,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.